Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/19/2025

Perioperative Metformin Management for Arthroscopy in Diabetic Patients

Introduction to Metformin Management

  • The American Diabetes Association recommends holding metformin on the day of surgery for perioperative management, as stated in their 2023 guidelines 1, 2, 3
  • Patients can take metformin with dinner the evening before surgery, assuming surgery is scheduled for the next day, according to the American Diabetes Association 2
  • The patient should not take metformin on the morning of surgery, as advised by the American Diabetes Association 1
  • The patient should not take any metformin doses on the actual day of the procedure, as recommended by the American Diabetes Association 2, 4

Practical Management Algorithm

  • Give metformin with dinner as usual if surgery is scheduled for the next day, as recommended by the American Diabetes Association 1, 2
  • Ensure the patient takes medication with food to minimize gastrointestinal side effects, as advised by the American Diabetes Association 5
  • Hold all metformin doses on the day of surgery, as recommended by the American Diabetes Association 1, 2, 3, 4
  • Target perioperative blood glucose of 100-180 mg/dL (5.6-10.0 mmol/L), as recommended by the American Diabetes Association 1, 2, 3
  • Monitor blood glucose every 2-4 hours while NPO, as advised by the American Diabetes Association 1, 2
  • Use short- or rapid-acting insulin as needed for hyperglycemia rather than oral agents, as recommended by the American Diabetes Association 1, 2

Special Considerations for Newly Diagnosed Diabetic Patients

  • Consider whether A1C optimization is needed if this is elective arthroscopy—target A1C <8% for elective surgery when possible, as recommended by the American Diabetes Association 1, 2, 3
  • Assess for undiagnosed diabetic complications (autonomic neuropathy, renal failure, ischemic heart disease) that increase perioperative risk, as advised by the American Diabetes Association 1, 2
  • Educate the patient about hypoglycemia risk if metformin is combined with insulin or insulin secretagogues perioperatively, as recommended by the American Diabetes Association 5

Postoperative Resumption

  • Resume metformin when the patient is eating and drinking normally and renal function is stable, as recommended by the American Diabetes Association 1
  • Restart at the previous dose with food to minimize GI side effects, as advised by the American Diabetes Association 5
  • Continue glucose monitoring until stable on the home regimen, as recommended by the American Diabetes Association 1

Critical Pitfall to Avoid

  • Do not confuse metformin with SGLT2 inhibitors, which require discontinuation 3-4 days before surgery due to euglycemic ketoacidosis risk, as warned by the American Diabetes Association 1, 2, 3